Clinical effect of Fuzheng Huayu Capsules combined with Magnesium Isoglycerate in the treatment of decompensated cirrhosis
LI Xiaoyong1 ZHANG Guoshun2
1.Department of Hepatology, Tangshan City Hospital for Infectious Diseases, Hebei Province, Tangshan 063000, China;
2.Department of Gastroenterology, Affiliated Hospital of North China University of Science and Technology, Hebei Province, Tangshan 063000, China
Abstract：Objective To investigate the effect of Fuzheng Huayu Capsules combined with Magnesium Isoglycerate on liver function and hepatic fibrosis in patients with decompensated cirrhosis. Methods A total of 120 cases with decompensated cirrhosis hospitalized in Tangshan City Hospital for Infectious Diseases and Affiliated Hospital of North China University of Technology from January 2015 to June 2017 were selected. According to random number table method, the patients were divided into control group and case group with 60 cases in each group. The control group was given conventional liver protection plus Magnesium Isoglycyrrhizate, and the case group was given conventional liver protection plus Magnesium Isoxalate and Fuzheng Huayu Capsules. Both groups were treated for 2 weeks. Clinical efficacy, liver fibrosis index and liver function of the two groups before and after treatment were observed. Results The effective rate was 95.00% in the case group, which was significantly higher than 81.67% in the control group, the difference was statistically significant (P ＜ 0.05). After treatment, compared with before treatment, The levels of total bilirubin (TBIL), alanine aminotransferase (ALT), aspartate aminotransferase (AST), layer adhesion protein (LN), type Ⅳ collagen (CIV), hyaluronic acid (HA), and before collagen Ⅲ type (PCⅢ) were decreased, while the levels of albumin (ALB) and cholinesterase (CHE) were increased the difference was statistically significant (P ＜ 0.05). After treatment, liver function and liver fibrosis index TBIL, ALT, AST, LN, CIV, HA, PCⅢ levels decreased, levels of ALB and CHE increased in the two groups, the differences were statistically significant (P ＜ 0.05). After treatment, compared with the control group, levels of TBIL, ALT, AST, LN, CIV, HA, PCⅢ decreased, while the levels of ALB and CHE increased in the case group, the differences were statistically significant (P ＜ 0.05). Conclusion The effect of Fuzheng Huayu Capsules combined with Magnesium Isoserate in the treatment of chronic liver cirrhosis is significant. It can obviously improve the liver function and the degree of liver fibrosis, and it has a synergistic effect.
2019, Vol. 16 
京公网安备 11010502046598号